/Sponsor / Executive Profile

David Dobkin

Executive

Aggregate Capital Deployment Matrix

Active/Searching: $75M (23.1%)

Professional Biography

David Dobkin has served as the Chief Financial Officer and a member of the Board since June 2019. He is a seasoned healthcare capital markets investment banker with a career dedicated to assisting high-growth life science, medical device, and healthcare IT companies in achieving their financial and strategic objectives. With extensive experience in the healthcare sector, Dobkin has established a strong track record in capital markets, focusing on the unique needs of companies within this dynamic industry. His expertise encompasses a wide range of financial strategies and investment opportunities, positioning him as a key player in the healthcare investment landscape.

Total Capital Deployed

$325,000,000

Active / Searching Capital:
$75,000,000

Transaction Volume

4 Transactions

Time-to-Liquidity (Months)

-

Merger Completion Rate

25.0%

Professional Network Intelligence

Top Sectors

  • Biopharmaceutical1 Deals
  • biopharmaceutical1 Deals

Syndicate Deal History

TickerCompanyStatusTrustPriceWarrantIPO DateTime LeftDeal ValueSectorBookrunner
LSAC
LifeSci Acquisition III Corp.
searching
75.0M
$10.00
-Jul 2021--GeneralLifeSci Capital LLC
LSAQ
LifeSci Acquisition II Corp.
closed
75.0M
$10.00
-Oct 2020Done-GeneralLifeSci Capital LLC
REVB
Revelation Biosciences, Inc.
closed
125.0M
$2.57
1/2Jul 2020Done-BiopharmaceuticalLifeSci Capital LLC
LSAC
Vincerx Pharma, Inc.
announced
50.0M
$10.00
1/2Feb 2020-
55.0M
biopharmaceuticalChardan Capital Markets, LLC